Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis
Abstract Introduction Patients with plaque psoriasis experience a variety of signs and symptoms that can impact daily life, which may not be evaluated by clinician-reported outcomes. This study aimed to develop and assess the content validity of a new patient-reported outcome (PRO) measure to captur...
Main Authors: | Alice B. Gottlieb, Valerie Ciaravino, Christopher Cioffi, Luke Peterson, Richard B. Warren |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-08-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s13555-020-00434-3 |
Similar Items
-
Bimekizumab in the Treatment of Plaque Psoriasis: Focus on Patient Selection and Perspectives
by: Camiña-Conforto G, et al.
Published: (2023-06-01) -
A case of scalp psoriasis resistant to ixekizumab treated with bimekizumab
by: Matteo Megna, MD, et al.
Published: (2023-08-01) -
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2023-08-01) -
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel
by: Joshua Burshtein, et al.
Published: (2024-02-01) -
The content validity of the PSS in patients with plaque psoriasis
by: A. M. Rentz, et al.
Published: (2017-09-01)